New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Learn More
Last Close
Sep 17  •  04:00PM ET
1.79
Dollar change
-0.12
Percentage change
-6.49
%
Index- P/E- EPS (ttm)-0.47 Insider Own- Shs Outstand551.86M Perf Week4.07%
Market Cap987.83M Forward P/E- EPS next Y- Insider Trans- Shs Float22.85M Perf Month1.70%
Enterprise Value813.71M PEG- EPS next Q- Inst Own0.03% Short Float0.15% Perf Quarter27.86%
Income-134.82M P/S66.88 EPS this Y- Inst Trans-17.18% Short Ratio0.93 Perf Half Y47.93%
Sales14.77M P/B4.96 EPS next Y- ROA-68.04% Short Interest0.03M Perf YTD31.62%
Book/sh0.36 P/C5.61 EPS next 5Y- ROE-79.90% 52W High2.35 -23.92% Perf Year77.23%
Cash/sh0.32 P/FCF968.46 EPS past 3/5Y17.63% 35.90% ROIC-67.69% 52W Low0.74 141.79% Perf 3Y86.28%
Dividend Est.- EV/EBITDA- Sales past 3/5Y35.10% 16.43% Gross Margin-1.90% Volatility7.81% 6.89% Perf 5Y0.56%
Dividend TTM- EV/Sales55.09 EPS Y/Y TTM-145.92% Oper. Margin-26.54% ATR (14)0.14 Perf 10Y-
Dividend Ex-DateAug 01, 2018 Quick Ratio14.18 Sales Y/Y TTM510.69% Profit Margin-912.89% RSI (14)50.81 Recom-
Dividend Gr. 3/5Y- - Current Ratio14.20 EPS Q/Q40.33% SMA200.64% Beta-0.65 Target Price4.00
Payout- Debt/Eq0.01 Sales Q/Q25.47% SMA501.12% Rel Volume0.06 Prev Close1.91
Employees27 LT Debt/Eq0.00 EarningsMar 28 BMO SMA20027.33% Avg Volume37.28K Price1.79
IPONov 03, 2017 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume2,365 Change-6.49%
Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Qingdao, China.